Literature DB >> 26884147

The role of extracellular-5'-nucleotidase/CD73 in glioma peritumoural brain edema.

Bo Wang1,2,3, Dong Wang4,5,6, ZhiZhong Zhu7, Wei Wang1,2,3, XueBin Zhang8, Fan Tang8, Yu Zhou1,2,3, HongGuang Wang1,2,3, MengYuan Liu3, Xin Yao1,2,3, XiaoLing Yan9.   

Abstract

During pathological conditions, extracellular-5'-nucleotidase/CD73 can protect neurons by reducing the permeability of the blood brain barrier. In recent years, it has been demonstrated that CD73 can negatively contribute to the growth of gliomas; however, the function of CD73 in glioma blood vessels is not clear. We analysed the expression of CD73 in 72 glioma patients using immunohistochemistry and correspondingly compared the results with the Edema index (EI). We established an in vitro model of the blood-tumour barrier and analysed the expression of CD73 in vascular endothelial cells. Lastly, CD73 expression was inhibited in endothelial cells, and the effects of this inhibition on tight junction structure and transendothelial resistance were observed. Compared to normal brains, the expression of CD73 in blood vessels of glioma patients was significantly decreased, and the amount was lower in the centre of the tumour than the periphery. The proportion of CD73-positive blood vessels had a positive correlation with the EI. The expression of CD73 in the in vitro endothelial cell blood-tumour barrier model was decreased. Lastly, inhibiting CD73 was found to decrease the expression of tight junction related proteins in endothelial cells and to decrease the value of transendothelial electric resistance. The expression of CD73 in glioma blood vessels was significantly decreased, which may play a multi-functional role in decreasing the expression of tight junction related proteins of brain microvascular endothelial cells and may also increase blood-tumour barrier permeability and accelerate the formation of PTBE.

Entities:  

Keywords:  Blood-tumour barrier; Extracellular-5′-nucleotidase/CD73; Peritumoural brain edema; Tight junction

Mesh:

Substances:

Year:  2016        PMID: 26884147     DOI: 10.1007/s10072-016-2510-4

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  29 in total

1.  Functional role of adenosine receptor subtypes in the regulation of blood-brain barrier permeability: possible implications for the design of synthetic adenosine derivatives.

Authors:  Marloes P Schaddelee; Heleen L Voorwinden; Erica W van Tilburg; Tony J Pateman; Adriaan P Ijzerman; Meindert Danhof; Albertus G de Boer
Journal:  Eur J Pharm Sci       Date:  2003-05       Impact factor: 4.384

2.  Development of a three-dimensional, all-human in vitro model of the blood-brain barrier using mono-, co-, and tri-cultivation Transwell models.

Authors:  Kathryn Hatherell; Pierre-Olivier Couraud; Ignacio A Romero; Babette Weksler; Geoffrey J Pilkington
Journal:  J Neurosci Methods       Date:  2011-05-14       Impact factor: 2.390

3.  CD73 represses pro-inflammatory responses in human endothelial cells.

Authors:  Jana Kg Grünewald; Anne J Ridley
Journal:  J Inflamm (Lond)       Date:  2010-02-05       Impact factor: 4.981

Review 4.  CD73: a novel target for cancer immunotherapy.

Authors:  Bin Zhang
Journal:  Cancer Res       Date:  2010-08-03       Impact factor: 12.701

5.  Association of pSTAT3-VEGF signaling pathway with peritumoral edema in newly diagnosed glioblastoma: an immunohistochemical study.

Authors:  Xing-Fu Wang; Guo-Shi Lin; Zhi-Xiong Lin; Yu-Peng Chen; Yao Chen; Jian-Dong Zhang; Wen-Long Tan
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

6.  Ecto-5'-nucleotidase expression is associated with the progression of renal cell carcinoma.

Authors:  Y I Yu; Wei Wang; Lei Song; Wentao Hu; Chi Dong; Hailong Pei; Guangming Zhou; Zhongjin Yue
Journal:  Oncol Lett       Date:  2015-04-23       Impact factor: 2.967

7.  Krüppel-like factor 4 regulates blood-tumor barrier permeability via ZO-1, occludin and claudin-5.

Authors:  Jun Ma; Ping Wang; Yunhui Liu; Lini Zhao; Zhen Li; Yixue Xue
Journal:  J Cell Physiol       Date:  2014-07       Impact factor: 6.384

8.  Assessment of angiogenesis by CD105 and nestin expression in peritumor tissue of glioblastoma.

Authors:  Gigliola Sica; Gina Lama; Carmelo Anile; Maria Concetta Geloso; Giuseppe La Torre; Pasquale De Bonis; Giulio Maira; Libero Lauriola; Meena Jhanwar-Uniyal; Annunziato Mangiola
Journal:  Int J Oncol       Date:  2011-01       Impact factor: 5.650

Review 9.  High interstitial fluid pressure - an obstacle in cancer therapy.

Authors:  Carl-Henrik Heldin; Kristofer Rubin; Kristian Pietras; Arne Ostman
Journal:  Nat Rev Cancer       Date:  2004-10       Impact factor: 60.716

10.  Glioma-induced remodeling of the neurovascular unit.

Authors:  Jisook Lee; Caren Lund-Smith; Alexandra Borboa; Ana M Gonzalez; Andrew Baird; Brian P Eliceiri
Journal:  Brain Res       Date:  2009-07-09       Impact factor: 3.252

View more
  3 in total

1.  Advances in clinical neurology through the journal "Neurological Sciences" (2015-2016).

Authors:  Ilaria Di Donato; Antonio Federico
Journal:  Neurol Sci       Date:  2017-01       Impact factor: 3.307

2.  Improved efficacy against malignant brain tumors with EGFRwt/EGFRvIII targeting immunotoxin and checkpoint inhibitor combinations.

Authors:  Vidyalakshmi Chandramohan; Xuhui Bao; Xin Yu; Scott Parker; Charlotte McDowall; Yen-Rei Yu; Patrick Healy; Annick Desjardins; Michael D Gunn; Matthias Gromeier; Smita K Nair; Ira H Pastan; Darell D Bigner
Journal:  J Immunother Cancer       Date:  2019-05-29       Impact factor: 13.751

3.  CD73: A Promising Biomarker in Cancer Patients.

Authors:  Roberta Turiello; Aldo Pinto; Silvana Morello
Journal:  Front Pharmacol       Date:  2020-11-16       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.